Hangzhou Coco Healthcare Products Co.Ltd. (301009) — Capital Reinvestment Ratio
Hangzhou Coco Healthcare Products Co.Ltd. (301009) has a Capital Reinvestment Ratio of 0.35x as of June 2025, meaning it reinvests 0% of its operating cash flow (CN¥12.21 Million) in capital expenditures (CN¥4.26 Million). See how much free cash does Hangzhou Coco Healthcare Products Co.Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Hangzhou Coco Healthcare Products Co.Ltd. Capital Reinvestment Ratio (2017–2024)
This chart tracks Hangzhou Coco Healthcare Products Co.Ltd.'s Capital Reinvestment Ratio across 7 annual periods.
Annual Capital Reinvestment Ratio for Hangzhou Coco Healthcare Products Co.Ltd. (2017–2024)
Year-by-year Capital Reinvestment Ratio for Hangzhou Coco Healthcare Products Co.Ltd. from 2017 to 2024. For live market cap and broader valuation context, see 301009 stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.44x | CN¥52.44 Million | CN¥75.35 Million | ▲ +395.7% |
| 2023 | 0.29x | CN¥227.70 Million | CN¥66.01 Million | ▼ -93.9% |
| 2021 | 4.76x | CN¥50.53 Million | CN¥240.45 Million | ▲ +753.6% |
| 2020 | 0.56x | CN¥395.86 Million | CN¥220.71 Million | ▼ -1.1% |
| 2019 | 0.56x | CN¥223.33 Million | CN¥125.86 Million | ▼ -28.3% |
| 2018 | 0.79x | CN¥114.26 Million | CN¥89.78 Million | ▲ +11.4% |
| 2017 | 0.71x | CN¥109.74 Million | CN¥77.41 Million | — |